Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 61 AL 75

Immune modulation to treat Alzheimer's disease

Duggan MR, Morgan DG, Price BR, Rajbanshi B, Martin-Peña A, Tansey MG, Walker KA.

Mol Neurodegener. 2025 Mar 31;20(1):39. doi: 10.1186/s13024-025-00828-x.

Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies

Kordi R, Andrews TJ, Hicar MD.

Virology. 2025 Jun;607:110523. doi: 10.1016/j.virol.2025.110523. Epub 2025 Mar 27.

Internalization of extracellular Tau oligomers in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Clin Chem. 2025;126:1-29. doi: 10.1016/bs.acc.2025.01.005. Epub 2025 Feb 12.

Reducing Alzheimer's disease risk with SGLT2 inhibitors: From glycemic control to neuroprotection

Alami M, Morvaridzadeh M, El Khayari A, Boumezough K, El Fatimy R, Khalil A, Fulop T, Berrougui H.

Ageing Res Rev. 2025 Jun;108:102751. doi: 10.1016/j.arr.2025.102751. Epub 2025 Apr 7.

Microbial diversity and fitness in the gut-brain axis: influences on developmental risk for Alzheimer's disease

Jamerlan AM, An SSA, Hulme JP.

Gut Microbes. 2025 Dec;17(1):2486518. doi: 10.1080/19490976.2025.2486518. Epub 2025 Apr 10.

Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer's Disease-Insights from In Vivo and In Vitro Studies

Sirimaharaj N, Thiankhaw K, Chattipakorn N, Chattipakorn SC.

Mol Neurobiol. 2025 Aug;62(8):10414-10426. doi: 10.1007/s12035-025-04904-7. Epub 2025 Apr 10.

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha YA, Rampes S, Tromp S, Boyanova ST, Fleckney A, Fidanboylu M, Thomas SA.

Pharmacol Rev. 2025 May;77(3):100052. doi: 10.1016/j.pharmr.2025.100052. Epub 2025 Mar 13.

Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease

Saadh MJ, Muhammad FA, Alazzawi TS, Fahdil AA, Athab ZH, Tuxtayev J, Alsaikhan F, Farhood B.

Mol Neurobiol. 2025 Aug;62(8):10577-10613. doi: 10.1007/s12035-025-04833-5. Epub 2025 Apr 12.

Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer's Disease with Therapeutic Implications

Song H, Lee J, Lee Y, Kim S, Kang S.

Int J Mol Sci. 2025 Apr 1;26(7):3272. doi: 10.3390/ijms26073272.

What Information do Systemic Pathological Changes Bring to the Diagnosis and Treatment of Alzheimer's Disease?

Zhou J, Sun X, Wang K, Shen M, Yu J, Yao Q, Hong H, Tang C, Wang Q.

Neurosci Bull. 2025 Jul;41(7):1289-1301. doi: 10.1007/s12264-025-01399-z. Epub 2025 Apr 21.

Targeting hypoxia-related pathobiology in Alzheimer's disease: strategies for prevention and treatment

Sharma V, Verma R, Singh TG.

Mol Biol Rep. 2025 Apr 23;52(1):416. doi: 10.1007/s11033-025-10520-4.

BIN1 and Alzheimer's disease: the tau connection

Dourlen P, Kilinc D, Landrieu I, Chapuis J, Lambert JC.

Trends Neurosci. 2025 May;48(5):349-361. doi: 10.1016/j.tins.2025.03.004. Epub 2025 Apr 22.

Unraveling the Complexity of Alzheimer's Disease: Insights into Etiology and Advancements in Treatment Strategies

Khan B, Iqbal MK, Khan MA, Khan H, Kiyani MM, Bashir S, Li S.

J Mol Neurosci. 2025 Apr 25;75(2):57. doi: 10.1007/s12031-025-02337-4.

Ceramides may Play a Central Role in the Pathogenesis of Alzheimer's Disease: a Review of Evidence and Horizons for Discovery

Kalkman HO, Smigielski L.

Mol Neurobiol. 2025 Nov;62(11):14424-14441. doi: 10.1007/s12035-025-04989-0. Epub 2025 Apr 28.

The hidden costs of imperfection: transcription errors in protein aggregation diseases

Sun Y, Vermulst M.

Curr Opin Genet Dev. 2025 Aug;93:102350. doi: 10.1016/j.gde.2025.102350. Epub 2025 Apr 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias